Influenza Vaccine

FluMist finally on track

FluMist finally on track

By Anna Lewcock

Manufacturing problems hindering production of MedImmune's
intranasal flu vaccine FluMist have finally been resolved at the
company's Liverpool, UK facility, with doses on track to be
available for this year's flu season.

Wyeth phases out NY facility

Wyeth phases out NY facility

By Wai Lang Chu

Pharmaceutical manufacturers, Wyeth, are to phase out manufacturing
at its US facility as part of its consolidation plans, which will
see the gradual phasing out of all operations at the New York
facility by late 2008.


Follow us


View more


Featured Suppliers